MG - MYASTHENIA GRAVIS
Clinical trials for MG - MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MG - MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MG - MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to ease daily struggles of myasthenia gravis
Disease control Recruiting nowThis study tests an experimental drug called empasiprubart in people with a specific type of generalized myasthenia gravis (gMG) who have AChR antibodies. The goal is to see if the drug is safe and can improve symptoms like muscle weakness that affect daily activities. Participan…
Matched conditions: MG - MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can tracking daily life unlock myasthenia gravis mysteries?
Knowledge-focused Recruiting nowThis registry study follows adults with myasthenia gravis (MG) over time to understand how symptoms, daily functioning, and quality of life change. Participants complete surveys about their symptoms, treatments, and challenges, and may share medical records. The goal is to gather…
Matched conditions: MG - MYASTHENIA GRAVIS
Sponsor: Autoimmune Neurology Alliance • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC